NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Again, follow your own logic. There’s no indication that Duffy received a significant amount of options that would make it worth the risk of leaving Merck for the opportunity to make his fortune. He was also not a member of the executive team, so no real promotion there, and NWBO is not an operating company nor is it a start up - it’s really just a SPV to raise capital, fund the trials, and hold the patents. All of which he would be aware, and would suggest to him that this company might not even be around after a couple of years.

As far as being a borrowed employee in effect, that’s not unusual. I actually work with a CEO that was employee of a large public company, who was then “assigned” to work in another organization that the public company is a minority investor. There are plenty of examples of that kind of arrangement. In fact, NWBO itself is a good example of employees that work for multiple organizations, namely Toucan and there other portfolio companies.

Right, this is unsettling and could mean anything, including him jumping a sinking ship. But the circumstantial evidence, including the timing, in my view Is weighted toward Duffy as a representative of Merck conducting due diligence.